Anti-Human CD28 Recombinant Antibody Fab Fragment (TGN1412) (CAT#: TAB-064LC-F(E))

• Ideal for T-cell Activation
  TGN1412 has greatly facilitated our research into T-cell activation. Its specific targeting of CD28 has provided consistent and reliable results in our in vitro assays.
• Flow Cytometry Compatible
  Using TGN1412 in flow cytometry has provided detailed insights into T-cell subsets. Its binding to CD28 has facilitated precise analysis of activation markers in our studies.
• Insightful Cytokine Production Studies
  Using TGN1412 to stimulate T-cells has provided comprehensive insights into cytokine production. Our cytokine assays consistently show reproducible and significant results.

1. Q 1: Is it possible to investigate T-cell activation in vitro using TGN1412?

   A: Yes, TGN1412 is specifically designed to target human CD28, making it an excellent tool for investigating T-cell activation and proliferation in vitro, particularly in human immune cell assays.

2. Q 2: In what ways does TGN1412 aid in the investigation of co-stimulatory signals in the activation of T cells?

   A: TGN1412 binds to CD28 on T-cells, delivering a co-stimulatory signal that is crucial for T-cell activation. This property allows researchers to dissect the role of co-stimulation in T-cell responses.

3. Q 3: Is TGN1412 appropriate for T-cell activation investigation using flow cytometry?

   A: Yes, TGN1412 can be used as a primary reagent in flow cytometry to study T-cell activation markers. It effectively binds to CD28, enabling detailed analysis of T-cell subsets.

View the frequently asked questions answered by Creative Biolabs Support.